{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/24/3316681/0/en/Absci-Announces-Positive-Interim-Phase-1-Data-from-the-HEADLINE-Trial-of-ABS-201-a-Novel-Antibody-Targeting-the-Prolactin-Receptor-PRLR.html", "message": "News view counter 813866 successfully enlarged"}